| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |